Liver transplantation has become the major therapy for acute liver failure (ALF) in
the United States. Survival rates range from 46% to 89%. Appropriate patient selection,
timely referral, and management of common complications have improved survival. Donor
organ shortage may prompt further use of extracorporeal support systems and auxiliary
transplantation in the future. This article reviews the American experience of liver
transplantation in patients with ALF.
fulminant - hepatic failure - transplantation
